Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina

Growth Factors

Volumn 16, Issue 1, 1998, Pages 1-9

  Robbins, Susan G ^a   Rajaratnam, Veeraramani S ^a   Penn, John S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

flk; flt; Immunohistochemistry; Vascular endothelial growth factor; VEGF receptor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RETINA INJURY; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA;

ANIMALIA;

EID: 0031770539     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199809017487     Document Type: Article

References (30)

1. Ahmed, A., Li, S.F., Dunk, C., Whittle, M.J., Rushton, D.I. and Tollason, T. (1995). Colocalization of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors 12, 235-243.
2. Aiello, L.P. (1997). Vascular endothelial growth factor: 20th-century mechanisms, 21st-century therapies. Invest. Ophthalmol. Vis. Sci. 38, 1647-1652.
3. Aiello, L.P., Avery, R.L., Arrigg, P.G., Keyt, B.A., Jampel, H.D., Shah, S. et al. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Eng. J. Med. 331, 1480-1487.
4. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L. and Smith, L.E.H. (1995). Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92, 10457-10461.
5. Boocock, C.A., Charnock-Jones, D.S., Sharkey, A.M., McLaren, J., Barker, P.J., Wright, K.A., Twenty, P.R. and Smith, S.K. (1995). Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. Natl. Cancer. Inst. 87, 506-516.
6. Brogi, E., Schatterman, G., Wu, T., Kim, E.A., Varticovski, L., Keyt, B. and Isner, J.M. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97, 469-476.
7. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Dvorak, H.F. and Senger, D.R. (1993). Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143, 1255-1262.
8. D'Amore, P.A. (1994). Mechanisms of retinal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 35, 3974-3979.
9. Ferrara, N. (1995). The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Research and Treatment 36, 127-137.
10. Frank, R.N. (1994). Vascular endothelial growth factor - its role in retinal vascular proliferation. New Eng. J. Med. 331, 1519-1520.
11. Guerrin, M., Moukadiri, H., Chollet, P. et al. (1995). Vasculo-tropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell Physiol. 164, 385-394.
12. Jakeman, L.B., Armanini, M., Phillips, H.S. and Ferrara, N. (1993). Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133, 848-859.
13. Jakeman, L.B., Winer, J., Bennett, G.L., Altar, C.A. and Ferrara, N. (1992). Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89, 244-253.
14. Kondo, S., Asano, M. and Suzuki, H. (1993). Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194, 1234-1241.
15. Li, J., Perrella, M.A., Tsai, J.-C, Yet, S.-F., Hsieh, C.-M., Yoshizumi, M., Patterson, C., Endege, W.O., Zhou, F. and Lee, M.-E. (1995). Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270, 308-312.
16. Malecaze, F., Clamens, S., Simorre-Pinatel, V., Mathis, A. el al. (1994). Detection of vascular endothelial growth factor mRNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthalmol. 112, 1476-1482.
17. Millauer, B., Wizigmann-Voos, S., Schnüren, H., Martinez, R., Moller, N.P.H., Risau, W. and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
18. Ortega, N. and Plouët, J. (1995). Expression of the VEGFR flk-1 mediates the proliferation of corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 36, S295.
19. Penn, J.S, Henry, M.M. and Tolman, B.L. (1994). Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatric Res. 36, 1-9.
20. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest. Ophthalmol. Vis. Sci. 36, 2063-2070.
21. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P. and Smith, L.E. (1995). Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905-909.
22. Plate, K.H., Breier, G., Millauer, B., Ullrich, A. and Risau, W. (1993). Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53, 5822-5827.
23. Robbins, S.G., Conaway, J.R., Tolman, B.L., Roberto, K.A. and Penn, J.S. (1997). Detection of vascular endothelial growth factor (VEGF) protein in vascular and nonvascular cells of the normal and oxygen-injured rat retina. Growth Factors 14, 229-241.
24. Sandner, P., Wolf, K., Bergmaier, U., Gess, B. and Kurtz, A. (1997). Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int. 51, 448-453.
25. Sioussat, T.M., Dvorak, H.F., Brock, T.A. and Senger, D.R. (1993). Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch. Biochem. Biophys. 301, 15-20.
26. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T. and Keshet, E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747.
27. Stone, J., Chan-Ling, T., Pe'er, J., Itin, A., Gnessin, H. and Keshet, E. (1996). Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 37, 290-299.
28. Thieme, H., Aiello, L.P., Takagi, H., Ferrara, N. and King, G.L. (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44, 98-103.
29. Tuder, R.M., Flook, B.E. and Voekel, N.F. (1995). Increased gene expression for VEGF and the VEGF receptors KDR/flk and fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95, 1798, 1807.
30. Wizigmann-Voos, S., Breier, G., Risau, W. and Plate, K.H. (1995). Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55, 1358-1364.